The results of open observational trial DIAMOND
Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2011
|
| Subjects: | |
| Online Access: | https://doaj.org/article/e7749dfe1c75471fb9d3a9e4c0656bbc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Aim. DIAMOND (DIAMicrON in Daily practice) is an open non-randomized observational trial aimed to estimate the efficacy and safety of gliclazide(Diamicron MB) in routine clinical practice. Materials and methods. 394 patients with poor control of type 2 diabetes mellitus (T2 DM), previously treated with diet or one of oral antidiabeticdrug (OAD), were switched to Diamicron MB. Previous therapy was left unchanged, except for a sulfonylurea or glinide that were canceled. Results. After 6 months of Diamicron MB therapy (30% monotherapy, 70% combined therapy) target HbA1c |
|---|